Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

The second of this two-part article explores what organizations should consider when trying to optimize a mixed team of ...

The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

Now that Covid vaccines are no longer recommended for healthy children and pregnant people, boosters could be a lot more ...

While the news isn’t great for vaccine manufacturers, it could have been worse. Shares of pure vaccine play Moderna rose 0.3% ...

Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...

The Department of Health and Human Services has canceled a contract with Moderna for the development of a bird flu vaccine.

A large prospective cohort study in Germany found no statistically significant increase in major birth defects following ...